Objective:
Pancreatic cancer is one of the leading causes of mortality in developed countries and a
lethal malignant neoplasm worldwide. This study aims to evaluate the epidemiology of pancreatic cancer incidence
and mortality and its relationship with HDI.
Methods:
This is a descriptive cross-sectional study that is based on cancer incidence data and cancer mortality
rates derived from the GLOBOCAN in 2018.
:
The incidence and mortality rates of Pancreas as well as Pancreas cancer distribution maps were derived for
world countries. The data analysis was conducted using a correlation test, and regression tests were used to
evaluate the correlation of the incidence and mortality of Pancreas with HDI. The statistical analysis was carried
out by Stata-14, and a significance level of 0.05 was considered.
Results:
The highest incidence of pancreatic cancer was reported in Asia with 214499 (46.7%) cases and the
lowest incidence was related to Oceania with 4529 cases (0.99%). The results showed a positive and significant
correlation between incidence (r = 0.764, P <0.0001) and mortality (r = 0.771, P <0.0001) of pancreatic cancer
and the HDI index. The results of ANOVA revealed that the highest mean incidence was related to the very high
HDI (P <0.0001) and the highest mortality was connected to the very high human development (P <0.0001). The
results exhibited that incidence was positively and significantly correlated with GNI (r = 0.497, P <0.0001), MYS
(r = 0.746, P <0.0001), LEB (r = 0.676, <0.0001) and EYS (r = 0.738, P <0.0001). Also, a significant positive
correlation was found between mortality and GNI (r = 0.507, P <0.0001), MYS (r = 0.745, P <0.0001), LEB (r =
0.679, <0.0001), and EYS (r = 0.748, P <0.0001).
Conclusion:
Given the higher incidence and mortality of pancreatic cancer in countries with HDI, it is necessary
to pay a greater attention to risk factors and appropriate planning to reduce these factors and minimize the impact
and mortality rate of this disease.